How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 147, 183-190
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populationsEMBO Molecular Medicine, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLLLeukemia Research, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- The structure of the FYR domain of transforming growth factor beta regulator 1Protein Science, 2010
- Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemiaNature Genetics, 2009
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 LeukemiasCancer Cell, 2008
- In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell PropertiesCancer Cell, 2008
- The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodelingHuman Molecular Genetics, 2006